163 related articles for article (PubMed ID: 36102453)
1. Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study.
Kreve F; Callejas GH; Jimenez LS; Marques RA; Chaim FDM; Utrini MP; Gestic MA; Ramos AC; Chaim EA; Cazzo E
Sao Paulo Med J; 2022; 140(6):739-746. PubMed ID: 36102453
[TBL] [Abstract][Full Text] [Related]
2. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
3. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
[TBL] [Abstract][Full Text] [Related]
4. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
[TBL] [Abstract][Full Text] [Related]
5. Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.
Norouzian Ostad A; Rajabzadeh F; Jamialahmadi T; Goshayeshi L; Ranjbar G; Rezvani R; Nematy M; Jangjoo A
Updates Surg; 2023 Apr; 75(3):659-669. PubMed ID: 36529770
[TBL] [Abstract][Full Text] [Related]
6. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
7. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.
Cazzo E; Jimenez LS; Pareja JC; Chaim EA
Obes Surg; 2015 Jun; 25(6):982-5. PubMed ID: 25381118
[TBL] [Abstract][Full Text] [Related]
8. Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series.
Eilenberg M; Langer FB; Beer A; Trauner M; Prager G; Staufer K
Obes Surg; 2018 Mar; 28(3):812-819. PubMed ID: 28965313
[TBL] [Abstract][Full Text] [Related]
9. Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.
Winder JS; Dudeck BS; Schock S; Lyn-Sue JR; Haluck RS; Rogers AM
Obes Surg; 2017 Feb; 27(2):376-380. PubMed ID: 27440167
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
[TBL] [Abstract][Full Text] [Related]
11. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
12. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
[TBL] [Abstract][Full Text] [Related]
13. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA
Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
[TBL] [Abstract][Full Text] [Related]
15. Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score-Matched Analysis.
Abbassi Z; Orci L; Meyer J; Sgardello SD; Goossens N; Rubbia-Brandt L; Spahr L; Buchs NC; Mönig SP; Toso C; Hagen ME; Jung MK
Obes Surg; 2022 Jan; 32(1):74-81. PubMed ID: 34546514
[TBL] [Abstract][Full Text] [Related]
16. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
17. ACCURACY OF ELASTOGRAPHY IN THE ASSESSMENT OF REDUCTION IN LIVER STEATOSIS AND FIBROSIS IN THE EARLY POSTOPERATIVE PERIOD AFTER BARIATRIC SURGERY.
Lima RR; Garcia JHP; Studart MS; Pinheiro FS; Pinto JOG; Sales LA; Soares LM; Santos PA
Arq Bras Cir Dig; 2022; 35():e1671. PubMed ID: 36043649
[TBL] [Abstract][Full Text] [Related]
18. Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.
Pedersen JS; Rygg MO; Serizawa RR; Kristiansen VB; Albrechtsen NJW; Gluud LL; Madsbad S; Bendtsen F
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501231
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
20. Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.
Jimenez LS; Mendonça Chaim FH; Mendonça Chaim FD; Utrini MP; Gestic MA; Chaim EA; Cazzo E
Obes Surg; 2018 Oct; 28(10):3131-3135. PubMed ID: 29725976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
